BUILDING BRIDGES TO BREAKTHROUGHS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BUILDING BRIDGES TO BREAKTHROUGHS Trademark

Serial Number: 98675526

BUILDING BRIDGES TO BREAKTHROUGHS is a trademark filed by Foundation for the National Institutes of Health, Inc. on July 31, 2024. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Foundation for the National Institutes of Health, Inc. (6 trademarks)

North Bethesda, MD 20852

Entity Type: 99

Trademark Details

Filing Date

July 31, 2024

Registration Date

Not Registered

Published for Opposition

April 7, 2026

Goods & Services

Charitable fundraising for others; financing the biomedical research of others; accepting and administering monetary charitable contributions to fund biomedical research and population health initiatives; grant making, namely, providing grants for biomedical research and population health initiatives; providing and financial administration of the grant of educational scholarships; providing scholarships, fellowship stipends, financial awards, and financial grants for biomedical research; financial services, namely, funding research awards in the field of biomedical sciences; financial services, namely accepting and administering financial and in-kind sponsorships and investments in the field of biomedical sciences

educational and entertainment services, namely, providing podcasts in the field of biomedical sciences

Business consultation and management regarding organizing, arranging, and operating public-private partnerships and alliances to advance biomedical research, solve complex healthcare challenges, and promote innovation in the life sciences fields; business project management services, namely, organizing and administering biomedical research programs and partnerships; business project management services, namely, organizing and managing research and development in the field of biomedical sciences; business project management services, namely, organizing and managing research and development in the field of biomedical sciences to accelerate new biomedical therapies, testing diagnostics, and potential cures of diseases and illnesses; business project management services for others in the fields of biomedical research and clinical trials; business advisory services, namely, strategic decision-making for others concerning biomedical research; business consulting and management in the fields of biomedical research and clinical trials; business consulting and management in the fields of biomedical research and clinical trials in the nature of clinical data and regulatory submission management for others; updating and maintaining data in computer databases focused on biomedical research; promoting increased collaboration within the scientific, research, patient advocacy, and medical communities to achieve advances in the field of healthcare; promoting the exchange of information and resources within the scientific, research, and medical communities to achieve advances in the field of healthcare; promoting public awareness of advances and discoveries in the life sciences field to foster increased healthcare equity; promoting public awareness of the importance of increased patient engagement and patient stakeholder input in the fields of biomedical research and clinical trial design, by means of public advocacy; promoting and facilitating the increased exchange of research and data in the field of biomedical sciences; promoting public awareness of technical and scientific investigation, research, and experimentation in the field of biomedical discoveries and innovation through support of public and private institutions; promoting public awareness among researchers and funding organizations and individuals concerning the need for innovation and advances in the field of biomedical research; promoting public awareness of the importance of innovation and collaboration to foster biomedical research and biomedical discoveries by means of public advocacy; promoting public awareness of scientific and medical progress and achievement in the field of biomedical sciences; charitable services in the nature of coordinating procurement and distribution of pharmaceutical drug donations for treatment and biomedical research purposes

providing a website featuring temporary use of non-downloadable software for accessing and operating databases in the field of biomedical research; database design and development in the field of biomedical research; maintenance of online databases for others; providing a website featuring technology that enables users to create, bookmark, annotate, and publicly share data in the field of biomedical research; providing an online network environment featuring technology that enables users to share data in the field of biomedical research; developing accreditation standards and guidelines for biomedical research to the order and specification of others

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 6, 2026 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 14, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 14, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 14, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 3, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 3, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2024 NWOS
NEW APPLICATION ENTERED
Jul 31, 2024 NWAP